Astrazeneca – The Mail & Guardian

/ 17 May 2022

Africa needs a billion Covid vaccines, but supply is slowing down

Data collected by Unicef shows an alarming drop-off in shipments arriving in the continent since the start of 2022

This content is restricted to subscribers only.

Join the M&G Community

Our commitment at the Mail & Guardian is to ensure every reader enjoys the finest experience. Join the M&G community and support us in delivering in-depth news to you consistently.

Subscription enables:

– M&G community membership
– independent journalism
– access to all premium articles & features
– a digital version of the weekly newspaper
– invites to subscriber-only events
– the opportunity to test new online features first

Already a subscriber?
Login here.

By Adam Oxford

Health

/ 15 March 2022

UK eyes up Covid-19 vaccine donations to slash £140m of foreign aid

The UK is set to count its excess Covid-19 vaccines as part of its aid budget, taking money away from other projects

By Samuel Horti , Rosa Furneaux , Samuel Lovett

Health

/ 22 December 2021

How your body can protect you from getting sick with Omicron

Omicron’s many mutations allow it to duck our body’s natural defence, but the immune system has a some tricks to prevent you from getting severely ill

By Aisha Abdool Karim

Coronavirus

/ 9 November 2021

How South Africa’s ivermectin use slips through the cracks

There is less demand for ivermectin when South Africa is between Covid-19 waves. But nobody is tracking how many people may be using the animal formulation

By Aisha Abdool Karim and Joan Van Dyk

Coronavirus

/ 11 October 2021

Advocates for ivermectin use severely flawed data

If ivermectin had dramatic results in combating Covid-19, it should perform well in any well-conducted, unbiased scientific study, but this is not the case

By Philip Machanick

Coronavirus

/ 2 July 2021

There is limited data on the Delta variant in SA, but vaccines remain effective

The Covid-19 J&J and Pfizer vaccines remain effective in protecting against severe sickness and hospitalisation

By Eunice Masson

National

/ 29 June 2021

Level 4 for all to avoid a Gauteng situation in other provinces

The national coronavirus command council explained why additional restrictions were placed on the entire country

By Eyaaz Matwadia

Coronavirus

/ 28 June 2021

Rise of the variants: What you need to know about the Delta variant in SA

SA’s lockdown regulations are tightening to better curb the spread of Covid-19, amid concerns that the Delta variant could drive a surge of infections

By Aisha Abdool Karim

Health

/ 11 June 2021

Three for three: Understanding the Covid-19 variants circulating during South Africa’s third wave

Which variants have been detected in SA and how do they differ? Each form of the virus behaves slightly differently and could affect what the pandemic looks like. We break it down.

By Aisha Abdool Karim

Coronavirus

/ 4 June 2021

South Africa’s not reaching herd immunity. Our new goal is containment

South Africa’s stop-start roll-out is not the only reason herd immunity is unrealistic for 2021. A constrained vaccine supply and new variants also play a role

By Bhekisisa Team

Coronavirus

/ 11 May 2021

Your guide to side effects: What you can expect after a Covid-19 jab

Soon, South Africa will start with its mass vaccine roll-out. We take a look at what to expect when you get vaccinated.

By Gopolang Makou

Coronavirus

/ 21 April 2021

How South Africa’s Covid vaccine injury fund will work

In the rare event that you experience a severe side-effect as a result of Covid-19 vaccines, this fund will pay you out

By Aisha Abdool Karim and Joan Van Dyk

Coronavirus

/ 19 April 2021

Pfizer backs down over ‘unreasonable’ terms in South Africa vaccine deal

Government, according to Mkhize, is “relieved” as Pfizer eventually conceded and removed the “problematic term”

By Madlen Davies and Rosa Furneaux

Opinion

/ 16 April 2021

Paddy Harper’s on the Rastazenica vaccine

Thursday. It’s Day 385 of the Covid-19 lockdown. Like most of my fellow South Africans, I’m wondering when, if ever, it will be my turn to get vaccinated. There’s no real answer coming from President Cyril Ramaphosa — or Health Minister Zweli Mkhize — at this stage. Lots of ifs, buts and maybes. There are […]

By Paddy Harper

Coronavirus

/ 1 April 2021

Top vaccinologist defends government’s Covid-19 vaccine rollout

A group of scientists has criticised the decision to sell SA’s AstraZeneca vaccine and says herd immunity mean vaccines will play a lesser role

By Chris Bateman

Coronavirus

/ 31 March 2021

Mkhize says SA will sign for 20-million more vaccine doses within two days

The government’s vaccine of choice will be Johnson & Johnson for the moment, the minister tells MPs

By Emsie Ferreira

Coronavirus

/ 19 March 2021

Blood-clot fears delay AstraZeneca vaccine roll-out

More than a dozen countries have suspended using the company’s Covid-19 vaccine, because of concerns about possible side effects.

By Agence France Presse

Coronavirus

/ 17 February 2021

We’re restoring the nation’s health, Ramaphosa says after Covid jab

About 80 000 doses of the Johnson & Johnson vaccine have been sent to about 50 sites for health workers to be vaccinated

By Eunice Masson

Health

/ 16 February 2021

How SA wants to sell the AstraZeneca vaccine for half the price and what the loss could be

Health Minister Zweli Mkhize says selling on the vaccines will stem wasteful expenditure, but people close to the discussions with AU say they will be sold on the cheap

This content is restricted to subscribers only.

Join the M&G Community

Our commitment at the Mail & Guardian is to ensure every reader enjoys the finest experience. Join the M&G community and support us in delivering in-depth news to you consistently.

Subscription enables:

– M&G community membership
– independent journalism
– access to all premium articles & features
– a digital version of the weekly newspaper
– invites to subscriber-only events
– the opportunity to test new online features first

Already a subscriber?
Login here.

By Lizeka Tandwa and Chris Bateman

Coronavirus

/ 16 February 2021

South Africa is offering its AstraZeneca vaccines to fellow African countries: Mkhize

Reselling the jabs will prevent money being wasted on a vaccine that is not particularly efficacious on the variant that is dominant in South Africa

By Emsie Ferreira

Health

/ 14 February 2021

No silver bullet for Covid-19, but rather a cocktail

It is no good waiting for a vaccine or ivermectin or other miracle cures, we just need to do what we can do now

By Philip Machanick

Opinion

/ 11 February 2021

Whoever switches off the lights should run the vaccine roll-out

We can’t be sure about dud drugs, divine intervention, or Sona promises but we can be sure the power will go off exactly on time

By Paddy Harper

Coronavirus

/ 11 February 2021

Most South Africans want to be innoculated against Covid, Ipsos survey finds

Most anti-vaxxers fear the potential side-effects of the vaccine

By Eunice Masson

Coronavirus

/ 10 February 2021

Johnson & Johnson vaccines could arrive in South Africa next week

We spoke to experts, looked at the data and relistened to the health department’s briefings to break down the revised roll-out plan

By Bhekisisa Team

Coronavirus

/ 9 February 2021

Government must find alternatives to AstraZeneca vaccine, say unions

Unions representing healthcare workers advise members to get vaccinated despite AstraZeneca postponement

By Marcia Zali

Coronavirus

/ 9 February 2021

Jury still out on pregnant women getting a Covid jab

Few trials have been carried out on women expecting babies

By Chris Bateman

Coronavirus

/ 8 February 2021

Second doses of AstraZeneca vaccine are still on their way to South Africa

The department of health and experts briefed the media on Sunday, after a study showed the vaccine is not highly effective against the new variant

By Eunice Masson

Coronavirus

/ 8 February 2021

South Africa pauses Covid-19 vaccine rollout after disappointing AstraZeneca results

SA’s one-million doses of the AstraZeneca vaccine will expire by early April — unless India’s Serum Institute can safely extend their use-by date.

By Laura López González

Health

/ 7 February 2021

Another Covid crisis: A vaccine apartheid endangering us all

The West bought billions of vaccines fast and cheap, leaving poorer nations paying through the nose for years to come

By Madlen Davies and Rosa Furneaux

Coronavirus

/ 1 February 2021

Why the Eastern Cape might take longer to roll out vaccinations

As healthcare workers prepare for the arrival of the Covid-19 vaccine, the Eastern Cape is still verifying vaccination sites, which could delay the inoculation process until April

By Chris Gilili

Coronavirus

/ 30 January 2021

Bill Gates, Big Pharma and entrenching the vaccine apartheid

Waiving intellectual property restrictions on Covid-19 vaccines could help the developing world. But India and South Africa’s pleas are falling on deaf ears

By Simon Allison

Opinion

/ 28 January 2021

Patents a litmus test for global vaccine rollout

As India and South Africa push for relief at the World Trade Organisation through intellectual property rights waivers, India’s history of getting concessions may be the proverbial tripping block

By Khaya Sithole

Older posts